Pharma News

The latest developments from pharmaceutical and biopharmaceutical companies, both innovator and generic-drug companies, and leading regulatory news.

Pfenex Inc., a clinical-stage biotechnology company developing and commercializing difficult-to-manufacture proteins, filed a registration statement with the US Securities and Exchange Commission on June 6, 2014 for a proposed initial...

The board of directors of the specialty pharmaceutical company, Allergan, Inc., has unanimously rejected the revised unsolicited proposal, dated May 30, 2014, by Pershing Square Capital Management, L.P. , Allergan's largest shareholder, and...

The specialty pharmaceutical company, Valeant Pharmaceuticals International, Inc., through its wholly owned subsidiary, Valeant Pharmaceuticals North America LLC, has received FDA approval for its new drug application for Jublia...

Amgen has appointed David W. Meline as executive vice president and chief financial officer (CFO), effective July 21, 2014. He will be responsible for Amgen's finance and investor relations operations, reporting to Robert A. Bradway , chairman and...

Actavis plc has finalized its previously announced agreement with Zydus Pharmaceuticals USA Inc. to settle all outstanding patent litigation related to Zydus' generic version of Asacol  HD (mesalamine) delayed-release tablets.  The terms...

Merck & Co. Inc, has agreed to acquire the biopharmaceutical company Idenix Pharmaceuticals Inc. for $24.50 per share in cash or approximately $3.85 billion. Idenix is engaged in the discovery and development of medicines for treating human...

arGEN-X, a clinical-stage biopharmaceutical company focused on developing differentiated therapeutic antibodies for treating cancer and severe autoimmune diseases, has formed a long-term strategic alliance with Shire Pharmaceuticals. The multi-year...

Citing family reason, Marijn Dekkers, CEO of Bayer AG, will step down at the end of 2016. To ensure continuity in key aspects of Bayer's future development, Bayer's supervisory board has appointed Werner Baumann, currently chief...